Press Release

Back

Incyte to Report Fourth Quarter and Year-End Financial Results

23 January, 2020

WILMINGTON, Del.--(BUSINESS WIRE)--Jan. 23, 2020-- Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2019 financial results conference call and webcast for 8:00 a.m. ET on Thursday, February 13, 2020.

The schedule for the press release and conference call/webcast is as follows:

  • Q4 & YE 2019 Press Release:

February 13, 2020 at 7:00 a.m. ET

  • Q4 & YE 2019 Conference Call:

February 13, 2020 at 8:00 a.m. ET

  • Domestic Dial-In Number:

877-407-3042

  • International Dial-In Number:

201-389-0864

  • Conference ID Number:

13698234

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13698234.

The live webcast with slides can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.

Source: Incyte

Incyte Contacts
Media
Catalina Loveman +1 302 498 6171
cloveman@incyte.com

Investors
Michael Booth, DPhil +1 302 498 5914
mbooth@incyte.com